Germany’s Merck said this week it has signed a non-binding Memorandum of Understanding (MoU) with South Korea’s Ministry of Trade, Industry and Energy (MOTIE), and...

CordenPharma is expanding strategically into synthetic oligonucleotide manufacturing at its plant at Boulder in the US state of Colorado. The two-phase investment is...

European NGOs have welcomed the EU’s plans for an overhaul of pharmaceutical legislation – the first in two decades – presented this week in Brussels. The drugs industry...

Shares of Prometheus Biosciences soared on news that US drugs major Merck will acquire the company in an all-cash deal valued at roughly $200 per share, or $10.8 billion...

Swiss WorldCargo, Swiss Airtainer, and B.P.L. have announced the launch of a self-sustaining airfreight container.

Lummus Technology and US biotech RWDC Industries have signed a Memorandum of Understanding to cooperate on deploying polyhydroxyalkanoates (PHAs), a group of natural...

German biotech and Covid vaccine maker BioNTech has sealed a major deal with Chinese biotech DualityBio to co-develop and commercialize two cancer antibody drug...

Solvay has agreed a strategic collaboration with Ginkgo Bioworks, which the Belgian chemical giant said is aimed at “building the leading platform for cell programming...

Austrian biotech Proxygen has announced a multi-year collaboration and license agreement with US drugmaker Merck & Co to identify and develop molecular glue degraders...

Conflicting decisions by federal courts in Texas and Washington on separate lawsuits involving mifepristone, one of the two drugs most widely used in medication-induced...